General Counsel AI, Inc.

SAN FRANCISCO, CA · Founded 2023 · CIK 0002036281 · Biotech

Oral GLP-1 peptide therapeutic platform and portable bioreactors for biologics production

general.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$63M
3 Form D · Nov 2025
10 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,646,596
Private capital raisedForm D · SEC$6,000,000
Private capital raisedForm D · SEC$55,589,951
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2178AVADIM HEALTH, INC.—$81M
2179ID4PHARMA, LLC——
2180ENABLE LIFE SCIENCES LLC——
2181General Counsel AI, Inc.—$63M
2182GIWOTECH INC.——
2183City Therapeutics——
2184CENNA BIOSCIENCES INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Rory O'DriscollDirector
  • Bardia PourvakilExecutive Officer · Promoter
  • Lucas SheinerDirector
  • Cecilia ZinitiDirector · Executive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.